Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Ligand Pharmaceuticals Incorporated (LGND)
USD309.25
-6.99 (-2.21%)
US NASDAQ Healthcare Biotechnology
Address
5980 Horton Street 94608
Jupiter, CA, US
Jupiter, CA, US
CEO
Todd C. Davis
Website
ligand.com
IPO
1992-11-18
CIK 886163 ISIN US53220K5048
Also trades on
NASDAQ Global Market · LGND (USD)
NASDAQ Global Market · LGNDV (USD)
Other OTC · LGNDZ (USD)
Other OTC · LGNXZ (USD)
Other OTC · LGNYZ (USD)
Other OTC · LGNZZ (USD)
Description
Ligand Pharmaceuticals Incorporated operates as a biopharmaceutical entity, primarily engaged in sourcing and advancing technologies to empower pharmaceutical companies globally in their efforts to discover and develop novel therapeutic solutions. Its diverse portfolio of commercialized products addresses a wide range of medical conditions. For hematologic malignancies, these include Kyprolis and Evomela, both targeting multiple myeloma, as well as Rylaze, a treatment for acute lymphoblastic leukemia and lymphoblastic lymphoma in both adult and pediatric patients. In the realm of infectious diseases, Ligand offers Veklury for moderate to severe COVID-19, Vaxneuvance for preventing invasive Streptococcus pneumoniae disease, and Pneumosil, a pneumococcal conjugate vaccine designed to protect children from pneumonia. Bone health solutions comprise Teriparatide injection for osteoporosis and Duavee for postmenopausal osteoporosis. Other key offerings include Zulresso, a Captisol-enabled formulation of brexanolone for postpartum depression; Nexterone, a Captisol-enabled amiodarone; and Noxafil-IV, a Captisol-enabled posaconazole for intravenous administration. The company’s comprehensive product lineup further extends to the Aziyo portfolio, featuring pericardial repair and CanGaroo envelope extracellular matrix products; Exemptia for autoimmune disorders; Vivitra for breast cancer; Bryxta and Zybev for a variety of indications; and Minnebro for managing hypertension. Beyond its own commercialized products, Ligand Pharmaceuticals collaborates with partners on numerous programs currently undergoing clinical development, targeting conditions such as cancer, seizure disorders, diabetes, cardiovascular ailments, muscle wasting, hepatic and renal diseases, and various other serious illnesses. The company also directly supplies Captisol materials, a proprietary technology frequently integrated into many of its drug formulations. Established in 1987, Ligand Pharmaceuticals is headquartered in Emeryville, California.
Market Cap & Enterprise Value
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD309.25
-6.99 (-2.21%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
321.5K
Beta
0.98
Float Shares
19.52M
Free Float %
97.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.36% | +4.25% | +3.64% | +20.33% | +9.91% | +17.00% | +109.42% | +185.10% | +78.57% | +88.44% | +382.45% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (17 ratings, all time)
Buy
Price Targets & DCF
Current price
309.25
Low
252.00
-18.5%
Consensus
267.75
-13.4%
Median
265.00
-14.3%
High
289.00
-6.5%
DCF (Unlevered)
44.12
-85.7%
DCF (Levered)
70.51
-77.2%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 7 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 4 |
259.75
-16.0%
|
| Last Quarter | 5 |
255.60
-17.3%
|
| Last Year | 12 |
240.00
-22.4%
|
| All Time | 19 |
201.63
-34.8%
|
Quality scores
Altman Z-Score
6.85
Safe zone
Piotroski F-Score
6 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
2 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+60.4% ★ Q1'26: +14.1% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+2,886.4% ★ Q1'26: +69.7% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%+54.1% ★ Q1'26: +93.7% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%+59.3% ★ Q1'26: +33.6% (vs Q1'25)
-
ROIC Biotechnology: -16.1%+16.9% ★ Q1'26: +6.2% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+11.0% Q1'26: +3.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×2.34× ★ Q1'26: 6.51× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 6 Rev. Ana. 5 EPS Ana. |
Dec 2027 5 Rev. Ana. 4 EPS Ana. |
Dec 2028 5 Rev. Ana. 4 EPS Ana. |
Dec 2029 2 Rev. Ana. 2 EPS Ana. |
Dec 2030 2 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
30.04M
est: 21.23M (+41.5%)
|
31.39M
est: 44.93M (-30.1%)
|
48.97M
est: 35.65M (+37.4%)
|
64.54M
est: 54.79M (+17.8%)
|
71.91M
est: 75.37M (-4.6%)
|
108.97M
est: 111.02M (-1.8%)
|
141.10M
est: 138.71M (+1.7%)
|
251.45M
est: 244.88M (+2.7%)
|
120.28M
est: 118.19M (+1.8%)
|
163.56M
est: 173.06M (-5.5%)
|
241.54M
est: 269.76M (-10.5%)
|
196.25M
est: 203.95M (-3.8%)
|
131.31M
est: 133.48M (-1.6%)
|
167.13M
est: 163.37M (+2.3%)
|
268.09M
est: 264.01M (+1.5%)
|
285.24M
274.63M – 302.20M
+8.0% YoY
|
364.18M
321.23M – 385.66M
+27.7% YoY
|
434.13M
428.86M – 439.40M
+19.2% YoY
|
510.93M
475.64M – 546.00M
+17.7% YoY
|
506.41M
471.43M – 541.16M
-0.9% YoY
|
| EBITDA |
1.74M
est: -35.64M (+104.9%)
|
3.94M
est: -357.8K (+1,201.6%)
|
18.65M
est: 9.41M (+98.1%)
|
23.37M
est: 12.71M (+83.8%)
|
29.96M
est: 68.42M (-56.2%)
|
55.18M
est: 16.32M (+238.2%)
|
81.15M
est: 60.08M (+35.1%)
|
238.30M
est: 195.26M (+22.0%)
|
876.12M
est: 55.86M (+1,468.3%)
|
56.67M
est: 35.61M (+59.1%)
|
142.77M
est: 100.29M (+42.4%)
|
81.20M
est: 98.40M (-17.5%)
|
100.84M
est: 73.03M (+38.1%)
|
40.79M
est: 89.39M (-54.4%)
|
192.74M
est: 144.46M (+33.4%)
|
156.07M
150.27M – 165.35M
+8.0% YoY
|
199.26M
175.76M – 211.02M
+27.7% YoY
|
237.54M
234.65M – 240.42M
+19.2% YoY
|
279.56M
260.25M – 298.75M
+17.7% YoY
|
277.08M
257.94M – 296.10M
-0.9% YoY
|
| EBIT |
254.0K
est: -43.25M (+100.6%)
|
1.22M
est: -10.15M (+112.0%)
|
15.98M
est: 9.62M (+66.2%)
|
20.71M
est: 16.45M (+25.9%)
|
27.33M
est: 29.10M (-6.1%)
|
20.80M
est: 36.02M (-42.2%)
|
68.63M
est: 58.79M (+16.7%)
|
221.61M
est: 129.14M (+71.6%)
|
832.38M
est: 30.05M (+2,669.8%)
|
28.71M
est: 20.81M (+38.0%)
|
91.82M
est: 69.06M (+33.0%)
|
37.81M
est: 63.66M (-40.6%)
|
64.32M
est: 45.08M (+42.7%)
|
5.56M
est: 55.18M (-89.9%)
|
158.96M
est: 89.17M (+78.3%)
|
96.34M
92.76M – 102.07M
+8.0% YoY
|
123.00M
108.50M – 130.26M
+27.7% YoY
|
146.63M
144.85M – 148.41M
+19.2% YoY
|
172.57M
160.65M – 184.42M
+17.7% YoY
|
171.04M
159.23M – 182.78M
-0.9% YoY
|
| Net Income |
10.18M
est: 31.30M (-67.5%)
|
-527.0K
est: -14.70M (+96.4%)
|
11.42M
est: 7.43M (+53.7%)
|
12.02M
est: 10.32M (+16.5%)
|
257.31M
est: 212.15M (+21.3%)
|
-1.64M
est: -2.28M (+28.2%)
|
12.56M
est: 10.20M (+23.1%)
|
143.32M
est: 124.12M (+15.5%)
|
629.30M
est: 539.06M (+16.7%)
|
-2.99M
est: -1.78M (-67.7%)
|
57.14M
est: 51.75M (+10.4%)
|
-33.36M
est: 41.02M (-181.3%)
|
52.15M
est: 48.43M (+7.7%)
|
-4.03M
est: 104.16M (-103.9%)
|
124.45M
est: 153.56M (-19.0%)
|
184.80M
178.58M – 191.01M
+20.3% YoY
|
227.78M
204.78M – 250.79M
+23.3% YoY
|
214.90M
205.56M – 307.11M
-5.7% YoY
|
280.26M
255.09M – 305.27M
+30.4% YoY
|
338.50M
308.11M – 368.71M
+20.8% YoY
|
| SGA |
14.98M
est: 7.60M (+97.0%)
|
16.11M
est: 41.89M (-61.5%)
|
17.98M
est: 11.73M (+53.3%)
|
22.57M
est: 17.28M (+30.6%)
|
24.38M
est: 30.49M (-20.0%)
|
26.62M
est: 21.57M (+23.4%)
|
28.65M
est: 25.01M (+14.6%)
|
37.73M
est: 28.10M (+34.3%)
|
41.88M
est: 38.51M (+8.8%)
|
60.01M
est: 53.76M (+11.6%)
|
46.79M
est: 45.00M (+4.0%)
|
70.06M
est: 61.09M (+14.7%)
|
52.79M
est: 47.20M (+11.8%)
|
78.65M
est: 57.77M (+36.1%)
|
92.45M
est: 93.37M (-1.0%)
|
100.87M
97.12M – 106.87M
+8.0% YoY
|
128.79M
113.60M – 136.38M
+27.7% YoY
|
153.52M
151.66M – 155.39M
+19.2% YoY
|
180.69M
168.20M – 193.09M
+17.7% YoY
|
179.08M
166.71M – 191.38M
-0.9% YoY
|
| EPS |
0.52
est: 0.77 (-32.5%)
|
-0.03
est: 0.01 (-376.0%)
|
0.56
est: 0.26 (+115.4%)
|
0.59
est: 1.10 (-46.1%)
|
13.00
est: 2.17 (+498.3%)
|
-0.08
est: 2.20 (-103.6%)
|
0.60
est: 1.99 (-69.8%)
|
5.96
est: 4.28 (+39.3%)
|
33.13
est: 1.94 (+1,611.4%)
|
-0.18
est: 2.53 (-107.1%)
|
3.46
est: 3.87 (-10.5%)
|
-1.98
est: 2.79 (-170.9%)
|
3.02
est: 2.39 (+26.5%)
|
-0.22
est: 5.66 (-103.9%)
|
6.44
est: 7.58 (-15.0%)
|
9.05
8.80 – 9.41
+19.4% YoY
|
11.16
10.09 – 12.36
+23.3% YoY
|
12.88
10.13 – 15.13
+15.4% YoY
|
13.81
12.57 – 15.04
+7.2% YoY
|
16.68
15.18 – 18.17
+20.8% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-08 | RBC Capital | Outperform | Outperform | Maintain |
| 2026-04-30 | HC Wainwright & Co. | Buy | Buy | Maintain |
| 2026-04-28 | RBC Capital | Outperform | Outperform | Maintain |
| 2026-04-15 | Citigroup | Buy | Buy | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-12 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-11 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-08 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-07 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-06 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-05 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-04 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-01 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-30 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-29 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-28 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-27 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-24 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-23 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-15 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
135.63M
OE per share TTM
6.66
Owner's Yield
3.08%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
13.6%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
218
Total invested
1.72B
Insider transactions (90d)
1
Beneficial owners (>5%)
22
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | (1) BlackRock, Inc. | 2.74M | 16.40% | 2.70M | — | 2.74M | — | HC | Delaware | 2022-01-27 | ↗ |
| 2 | 10 | 2.22M | 8.10% | 2.22M | — | 2.22M | — | CO | Delaware | 2020-02-12 | ↗ |
| 3 | Ligand Pharmaceuticals Incorporated | 2.22M | 4.10% | 2.22M | — | 2.22M | — | CO | Delaware | 2021-01-15 | ↗ |
| 4 | The Vanguard Group - 23-1945930 | 1.72M | 10.27% | — | 15.0K | 1.69M | 29.7K | IA | Pennsylvania | 2022-02-10 | ↗ |
| 5 | EIN #00-0000000 | 1.44M | 8.60% | — | 1.44M | — | 1.44M | IA, HC | — | 2022-02-10 | ↗ |
| 6 | William Blair Investment Management, LLC | 1.40M | 8.40% | 1.24M | — | 1.40M | — | IA | Delaware | 2022-02-10 | ↗ |
| 7 | 01-0825912 | 1.01M | 6.00% | — | 1.01M | — | 1.01M | IV | — | 2022-02-10 | ↗ |
| 8 | Macquarie Group Limited | 987.2K | 5.66% | — | — | — | — | HC | Sydney, New South Wales Australia | 2024-02-14 | ↗ |
| 9 | Macquarie Investment Management Business Trust | 987.2K | 5.66% | 987.2K | — | 987.2K | — | IA | Sydney, New South Wales Australia | 2024-02-14 | ↗ |
| 10 | Macquarie Management Holdings Inc | 987.2K | 5.66% | 987.2K | — | 987.2K | — | HC | Sydney, New South Wales Australia | 2024-02-14 | ↗ |
| 11 | 10. | 893.9K | 5.56% | 890.3K | — | 890.3K | — | HC | State of Delaware | 2021-02-12 | ↗ |
| 12 | STATE STREET CORPORATION | 887.4K | 5.31% | — | 851.6K | — | — | HC | BOSTON, MASSACHUSETTS | 2022-02-11 | ↗ |
| 13 | BANK OF AMERICA CORP /DE/56-0906609 | 211.7K | 1.30% | — | 211.0K | — | 211.6K | HC | — | 2021-02-08 | ↗ |
| 14 | Wasatch Advisors, Inc. 87-0319391 | 195.2K | 1.20% | 195.2K | — | 195.2K | — | IA | — | 2022-02-11 | ↗ |
| 15 | Cardinal Capital Management, LLC | 162.6K | 1.00% | 139.5K | — | 162.6K | — | IA, OO | — | 2022-02-14 | ↗ |
| 16 | GOLDMAN SACHS & CO. LLC | 52.4K | 0.30% | — | — | 51.4K | 51.4K | BD, IA, OO | — | 2024-11-08 | ↗ |
| 17 | THE GOLDMAN SACHS GROUP, INC. | 52.4K | 0.30% | — | — | 51.4K | 51.4K | HC, CO | — | 2024-11-08 | ↗ |
| 18 | 15,575 | 15.6K | 0.10% | 15.6K | — | 15.6K | — | CO | State of Delaware | 2021-02-12 | ↗ |
| 19 | 0.00% | 778.00 | 0.00% | 778.00 | — | 778.00 | — | CO | State of Delaware | 2021-02-12 | ↗ |
| 20 | Macquarie Investment Management Global Limited | 249.00 | 0.00% | 249.00 | — | 249.00 | — | CO | — | 2022-02-14 | ↗ |
| 21 | 13-3127734 | — | 0.00% | — | — | — | — | HC | Delaware | 2021-02-11 | ↗ |
| 22 | 26-0385758 | — | 0.00% | — | — | — | — | IA | Delaware | 2021-02-11 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
218
-135 vs prev Q
New positions
34
Closed positions
165
Increased
107
Reduced
69
Put/Call ratio
0.51
Calls held
4.1K
Puts held
2.1K
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | MACQUARIE MANAGEMENT HOLDINGS, INC. | 644.1K +644.1K (+100.0%) | 121.78B +121.8B (+100.0%) | 3.33% +3.326 pp | 0.18% +0.184 pp | USD189.07 +0.0% | 1 qtrs NEW |
| 2 | BLACKROCK, INC. | 2.94M +55.7K (+1.9%) | 555.91M +44.9M (+8.8%) | 15.18% +0.288 pp | 0.01% +0.001 pp | USD101.78 +85.8% | 6 qtrs — |
| 3 | VANGUARD GROUP INC | 2.07M -2.4K (-0.1%) | 392.11M +24.3M (+6.6%) | 10.71% -0.012 pp | 0.01% +0.000 pp | USD95.00 +99.0% | 61 qtrs — |
| 4 | JANUS HENDERSON GROUP PLC | 995.4K -47.0K (-4.5%) | 188.20M +3.6M (+1.9%) | 5.14% -0.243 pp | 0.08% +0.000 pp | USD121.16 +56.0% | 35 qtrs — |
| 5 | STATE STREET CORP | 751.2K +1.8K (+0.2%) | 142.03M +9.3M (+7.0%) | 3.88% +0.010 pp | 0.00% +0.000 pp | USD100.22 +88.7% | 51 qtrs — |
| 6 | FMR LLC | 579.2K +121.9K (+26.7%) | 109.50M +28.5M (+35.2%) | 2.99% +0.630 pp | 0.01% +0.001 pp | USD176.23 +7.3% | 60 qtrs — |
| 7 | CHICAGO CAPITAL, LLC | 561.4K -7.2K (-1.3%) | 106.15M +5.4M (+5.4%) | 2.90% -0.037 pp | 2.62% +0.143 pp | USD94.41 +100.3% | 23 qtrs — |
| 8 | INVESCO LTD. | 516.5K +138.2K (+36.5%) | 97.65M +30.6M (+45.7%) | 2.67% +0.713 pp | 0.02% +0.004 pp | USD150.59 +25.6% | 53 qtrs — |
| 9 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 507.0K -34.8K (-6.4%) | 95.86M -120.3K (-0.1%) | 2.62% -0.180 pp | 0.03% +0.001 pp | USD134.00 +41.1% | 5 qtrs — |
| 10 | STEPHENS INVESTMENT MANAGEMENT GROUP LLC | 501.0K -53.5K (-9.6%) | 94.73M -3.5M (-3.6%) | 2.59% -0.276 pp | 1.23% -0.040 pp | USD80.22 +135.7% | 50 qtrs — |
| 11 | FRANKLIN RESOURCES INC | 496.2K +266.3K (+115.9%) | 93.81M +53.1M (+130.4%) | 2.56% +1.375 pp | 0.02% +0.013 pp | USD155.00 +22.0% | 11 qtrs — |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 493.6K +19.4K (+4.1%) | 93.34M +9.3M (+11.1%) | 2.55% +0.100 pp | 0.01% +0.000 pp | USD101.23 +86.8% | 61 qtrs — |
| 13 | CONGRESS ASSET MANAGEMENT CO /MA | 480.1K -187.2K (-28.1%) | 90.77M -27.4M (-23.2%) | 2.48% -0.967 pp | 0.64% -0.148 pp | USD89.38 +111.5% | 7 qtrs — |
| 14 | DIMENSIONAL FUND ADVISORS LP | 433.0K -90.9K (-17.4%) | 81.87M -10.9M (-11.8%) | 2.24% -0.470 pp | 0.02% -0.003 pp | USD86.95 +117.4% | 51 qtrs — |
| 15 | GOLDMAN SACHS GROUP INC | 429.0K +61.2K (+16.6%) | 81.11M +16.0M (+24.5%) | 2.22% +0.316 pp | 0.01% +0.002 pp | USD167.37 +13.0% | 61 qtrs — |
| 16 | LOOMIS SAYLES & CO L P | 382.7K -17.9K (-4.5%) | 72.35M +1.4M (+2.0%) | 1.98% -0.092 pp | 0.09% +0.003 pp | USD91.43 +106.8% | 7 qtrs — |
| 17 | UBS ASSET MANAGEMENT AMERICAS INC | 363.6K -13.0K (-3.5%) | 68.74M +2.0M (+3.0%) | 1.88% -0.067 pp | 0.01% +0.000 pp | USD111.09 +70.2% | 55 qtrs — |
| 18 | DEUTSCHE BANK AG\ | 307.9K +339.0 (+0.1%) | 58.21M +3.7M (+6.9%) | 1.59% +0.002 pp | 0.02% +0.001 pp | USD82.58 +129.0% | 50 qtrs — |
| 19 | RICE HALL JAMES & ASSOCIATES, LLC | 279.6K -14.9K (-5.0%) | 52.87M +703.2K (+1.3%) | 1.44% -0.077 pp | 2.91% +0.066 pp | USD105.77 +78.8% | 44 qtrs — |
| 20 | RANGER INVESTMENT MANAGEMENT, L.P. | 270.0K -5.4K (-1.9%) | 51.05M +2.3M (+4.7%) | 1.39% -0.028 pp | 3.50% +0.101 pp | USD101.60 +86.1% | 8 qtrs — |
| 21 | VICTORY CAPITAL MANAGEMENT INC | 256.4K +1.6K (+0.6%) | 48.48M +3.3M (+7.4%) | 1.32% +0.008 pp | 0.03% +0.001 pp | USD167.18 +13.1% | 43 qtrs — |
| 22 | NORTHERN TRUST CORP | 250.6K -15.3K (-5.8%) | 47.39M +276.0K (+0.6%) | 1.29% -0.079 pp | 0.01% +0.000 pp | USD93.49 +102.2% | 51 qtrs — |
| 23 | ASHFORD CAPITAL MANAGEMENT INC | 213.8K -30.7K (-12.5%) | 40.42M -2.9M (-6.7%) | 1.10% -0.158 pp | 4.50% -0.320 pp | USD78.54 +140.7% | 8 qtrs — |
| 24 | PRIVATE CAPITAL MANAGEMENT, LLC | 208.9K -18.3K (-8.0%) | 39.50M -743.7K (-1.8%) | 1.08% -0.094 pp | 3.62% +0.026 pp | USD96.33 +96.3% | 7 qtrs — |
| 25 | VILLERE ST DENIS J & CO LLC | 202.5K -77.5K (-27.7%) | 38.28M -11.3M (-22.8%) | 1.05% -0.400 pp | 3.84% -0.932 pp | USD78.89 +139.7% | 24 qtrs — |
| 26 | MORGAN STANLEY | 193.4K +4.7K (+2.5%) | 36.57M +3.1M (+9.4%) | 1.00% +0.024 pp | 0.00% +0.000 pp | USD101.92 +85.5% | 51 qtrs — |
| 27 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 184.3K +2.0K (+1.1%) | 34.84M +2.5M (+7.9%) | 0.95% +0.010 pp | 0.01% +0.000 pp | USD118.48 +59.6% | 57 qtrs — |
| 28 | IMPAX ASSET MANAGEMENT GROUP PLC | 165.2K -35.0K (-17.5%) | 31.24M -4.2M (-11.9%) | 0.85% -0.181 pp | 0.20% -0.012 pp | USD101.55 +86.2% | 30 qtrs — |
| 29 | UBS GROUP AG | 143.1K +31.1K (+27.8%) | 27.05M +7.2M (+36.4%) | 0.74% +0.161 pp | 0.00% +0.001 pp | USD160.83 +17.6% | 45 qtrs — |
| 30 | RUSSELL INVESTMENTS GROUP, LTD. | 138.5K +2.3K (+1.7%) | 26.18M +2.1M (+8.6%) | 0.71% +0.012 pp | 0.03% +0.001 pp | USD91.93 +105.7% | 37 qtrs — |
| 31 | WELLS FARGO & COMPANY/MN | 132.6K +17.5K (+15.2%) | 25.08M +4.7M (+22.9%) | 0.68% +0.090 pp | 0.00% +0.001 pp | USD169.96 +11.2% | 57 qtrs — |
| 32 | FIERA CAPITAL CORP | 131.2K +131.2K (+100.0%) | 24.81M +24.8M (+100.0%) | 0.68% +0.678 pp | 0.08% +0.079 pp | USD189.07 +0.0% | 1 qtrs NEW |
| 33 | FISHER ASSET MANAGEMENT, LLC | 130.9K +21.9K (+20.1%) | 24.74M +5.4M (+28.2%) | 0.68% +0.113 pp | 0.01% +0.002 pp | USD112.44 +68.2% | 47 qtrs — |
| 34 | JACOBS LEVY EQUITY MANAGEMENT, INC | 126.8K -935.0 (-0.7%) | 23.97M +1.3M (+6.0%) | 0.65% -0.005 pp | 0.09% +0.003 pp | USD105.44 +79.3% | 4 qtrs — |
| 35 | BANK OF MONTREAL /CAN/ | 126.1K +294.0 (+0.2%) | 23.83M +1.6M (+7.0%) | 0.65% +0.002 pp | 0.01% 0.000 pp | USD172.79 +9.4% | 9 qtrs — |
| 36 | DRIEHAUS CAPITAL MANAGEMENT LLC | 122.3K -40.5K (-24.9%) | 23.13M -5.7M (-19.8%) | 0.63% -0.209 pp | 0.16% -0.050 pp | USD103.74 +82.3% | 6 qtrs — |
| 37 | BANK OF NEW YORK MELLON CORP | 122.3K -5.2K (-4.1%) | 23.12M +531.5K (+2.4%) | 0.63% -0.027 pp | 0.00% 0.000 pp | USD82.05 +130.4% | 61 qtrs — |
| 38 | BANK OF AMERICA CORP /DE/ | 120.2K -2.2K (-1.8%) | 22.72M +1.0M (+4.8%) | 0.62% -0.015 pp | 0.00% +0.000 pp | USD96.21 +96.5% | 52 qtrs — |
| 39 | ABRDN PLC | 119.3K -70.4K (-37.1%) | 22.56M -11.1M (-32.9%) | 0.62% -0.364 pp | 0.03% -0.018 pp | USD101.43 +86.4% | 22 qtrs — |
| 40 | GW&K INVESTMENT MANAGEMENT, LLC | 117.4K +85.3K (+265.4%) | 22.20M +16.5M (+290.1%) | 0.61% +0.440 pp | 0.19% +0.142 pp | USD167.25 +13.0% | 17 qtrs — |
| 41 | NOMURA HOLDINGS INC | 116.4K -4.9K (-4.1%) | 22.01M +512.7K (+2.4%) | 0.60% -0.026 pp | 0.03% -0.004 pp | USD177.14 +6.7% | 2 qtrs — |
| 42 | ROYAL BANK OF CANADA | 108.8K +5.3K (+5.1%) | 20.57M +2.2M (+12.2%) | 0.56% +0.027 pp | 0.00% +0.000 pp | USD171.07 +10.5% | 44 qtrs — |
| 43 | LEGAL & GENERAL GROUP PLC | 108.4K +13.0 (+0.0%) | 20.49M +1.3M (+6.7%) | 0.56% +0.000 pp | 0.00% +0.000 pp | USD115.35 +63.9% | 46 qtrs — |
| 44 | NEW YORK STATE COMMON RETIREMENT FUND | 107.5K +21.0K (+24.3%) | 20.33M +5.0M (+32.6%) | 0.56% +0.108 pp | 0.03% +0.007 pp | USD118.67 +59.3% | 49 qtrs — |
| 45 | PENN CAPITAL MANAGEMENT COMPANY, LLC | 98.8K -8.4K (-7.9%) | 18.71M -314.2K (-1.7%) | 0.51% -0.047 pp | 1.49% +0.029 pp | USD101.02 +87.2% | 6 qtrs — |
| 46 | AMERIPRISE FINANCIAL INC | 98.3K -3.0K (-2.9%) | 18.58M +644.6K (+3.6%) | 0.51% -0.015 pp | 0.00% +0.000 pp | USD106.17 +78.1% | 55 qtrs — |
| 47 | PRINCIPAL FINANCIAL GROUP INC | 93.8K -772.0 (-0.8%) | 17.74M +982.6K (+5.9%) | 0.48% -0.004 pp | 0.01% +0.001 pp | USD115.07 +64.3% | 51 qtrs — |
| 48 | CLARK CAPITAL MANAGEMENT GROUP, INC. | 79.8K -3.2K (-3.9%) | 15.08M +382.6K (+2.6%) | 0.41% -0.017 pp | 0.09% +0.001 pp | USD116.92 +61.7% | 6 qtrs — |
| 49 | ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 71.8K -36.6K (-33.8%) | 13.65M -5.8M (-29.7%) | 0.37% -0.189 pp | 0.02% -0.009 pp | USD107.77 +75.4% | 17 qtrs — |
| 50 | DANA INVESTMENT ADVISORS, INC. | 69.4K -3.3K (-4.5%) | 13.12M +249.9K (+1.9%) | 0.36% -0.017 pp | 0.38% +0.005 pp | USD75.38 +150.8% | 8 qtrs — |
| 51 | FIRST TRUST ADVISORS LP | 69.2K +17.5K (+33.9%) | 13.09M +3.9M (+42.9%) | 0.36% +0.091 pp | 0.01% +0.003 pp | USD116.32 +62.5% | 22 qtrs — |
| 52 | PUBLIC SECTOR PENSION INVESTMENT BOARD | 68.1K -8.3K (-10.9%) | 12.88M -663.0K (-4.9%) | 0.35% -0.043 pp | 0.04% -0.006 pp | USD117.34 +61.1% | 21 qtrs — |
| 53 | CASTLEARK MANAGEMENT LLC | 66.7K +2.1K (+3.2%) | 12.62M +1.2M (+10.1%) | 0.34% +0.011 pp | 0.37% +0.049 pp | USD177.51 +6.5% | 11 qtrs — |
| 54 | PICTET ASSET MANAGEMENT HOLDING SA | 64.4K -2.6K (-3.9%) | 12.55M +941.3K (+8.1%) | 0.33% -0.015 pp | 0.01% +0.001 pp | USD66.04 +186.3% | 10 qtrs — |
| 55 | KORNITZER CAPITAL MANAGEMENT INC /KS | 60.3K -30.8K (-33.8%) | 11.41M -4.7M (-29.4%) | 0.31% -0.159 pp | 0.24% -0.087 pp | USD100.39 +88.3% | 38 qtrs — |
| 56 | ESSEX INVESTMENT MANAGEMENT CO LLC | 60.0K -1.1K (-1.8%) | 11.35M +517.3K (+4.8%) | 0.31% -0.006 pp | 1.73% +0.073 pp | USD85.35 +121.5% | 7 qtrs — |
| 57 | ADVISOR GROUP HOLDINGS, INC. | 59.4K -41.3K (-41.0%) | 11.23M -6.6M (-36.9%) | 0.31% -0.213 pp | 0.02% -0.009 pp | USD172.86 +9.4% | 24 qtrs — |
| 58 | GRANITE INVESTMENT PARTNERS, LLC | 57.9K -3.7K (-6.0%) | 10.95M +36.7K (+0.3%) | 0.30% -0.019 pp | 0.65% +0.029 pp | USD100.76 +87.6% | 6 qtrs — |
| 59 | RHUMBLINE ADVISERS | 56.7K -2.7K (-4.5%) | 10.73M +201.1K (+1.9%) | 0.29% -0.014 pp | 0.01% +0.000 pp | USD98.68 +91.6% | 52 qtrs — |
| 60 | JPMORGAN CHASE & CO | 56.6K +16.9K (+42.5%) | 10.70M +3.7M (+52.1%) | 0.29% +0.086 pp | 0.00% +0.000 pp | USD119.82 +57.8% | 41 qtrs — |
| 61 | NORDEA INVESTMENT MANAGEMENT AB | 53.7K -7.3K (-11.9%) | 10.19M -492.9K (-4.6%) | 0.28% -0.038 pp | 0.01% -0.001 pp | USD113.83 +66.1% | 39 qtrs — |
| 62 | SEI INVESTMENTS CO | 46.4K +18.9K (+69.1%) | 8.77M +3.9M (+80.5%) | 0.24% +0.098 pp | 0.01% +0.003 pp | USD138.05 +37.0% | 44 qtrs — |
| 63 | F/M INVESTMENTS LLC | 46.1K -5.3K (-10.4%) | 8.72M -396.7K (-4.4%) | 0.24% -0.028 pp | 0.33% -0.020 pp | USD84.99 +122.5% | 7 qtrs — |
| 64 | WCM INVESTMENT MANAGEMENT, LLC | 45.6K +45.6K (+100.0%) | 8.68M +8.7M (+100.0%) | 0.24% +0.236 pp | 0.02% +0.018 pp | USD189.07 +0.0% | 1 qtrs NEW |
| 65 | PRUDENTIAL FINANCIAL INC | 45.6K +16.6K (+57.2%) | 8.63M +3.5M (+67.8%) | 0.24% +0.086 pp | 0.01% +0.004 pp | USD131.20 +44.1% | 55 qtrs — |
| 66 | LISANTI CAPITAL GROWTH, LLC | 43.7K +14.1K (+47.4%) | 8.27M +3.0M (+57.3%) | 0.23% +0.073 pp | 1.96% +0.674 pp | USD162.96 +16.0% | 6 qtrs — |
| 67 | UNIPLAN INVESTMENT COUNSEL, INC. | 42.4K +188.0 (+0.4%) | 8.01M +538.8K (+7.2%) | 0.22% +0.001 pp | 0.80% +0.072 pp | USD84.42 +124.0% | 8 qtrs — |
| 68 | AMERICAN CENTURY COMPANIES INC | 40.9K -4.7K (-10.3%) | 7.73M -347.8K (-4.3%) | 0.21% -0.024 pp | 0.00% 0.000 pp | USD93.07 +103.1% | 14 qtrs — |
| 69 | SWISS NATIONAL BANK | 38.6K +1.2K (+3.2%) | 7.30M +673.1K (+10.2%) | 0.20% +0.006 pp | 0.00% +0.001 pp | USD92.59 +104.2% | 51 qtrs — |
| 70 | NUVEEN, LLC | 37.6K -499.0 (-1.3%) | 7.11M +360.2K (+5.3%) | 0.19% -0.003 pp | 0.00% +0.000 pp | USD105.14 +79.8% | 4 qtrs — |
| 71 | D. E. SHAW & CO., INC. | 36.6K +19.0K (+108.7%) | 6.91M +3.8M (+122.8%) | 0.19% +0.098 pp | 0.00% +0.002 pp | USD170.94 +10.6% | 3 qtrs — |
| 72 | BNP PARIBAS ARBITRAGE, SNC | 35.0K +30.9K (+754.3%) | 6.61M +5.9M (+811.8%) | 0.18% +0.159 pp | 0.00% +0.003 pp | USD181.94 +3.9% | 51 qtrs — |
| 73 | BARCLAYS PLC | 33.0K -10.5K (-24.1%) | 6.24M +1.9M (+43.4%) | 0.17% -0.055 pp | 0.00% +0.000 pp | USD104.60 +80.8% | 51 qtrs — |
| 74 | ENVESTNET ASSET MANAGEMENT INC | 27.7K -4.2K (-13.1%) | 5.24M -409.6K (-7.2%) | 0.14% -0.022 pp | 0.00% 0.000 pp | USD100.28 +88.5% | 48 qtrs — |
| 75 | NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 27.0K +— (+0.0%) | 5.10M +321.0K (+6.7%) | 0.14% +0.000 pp | 0.01% +0.001 pp | USD90.89 +108.0% | 49 qtrs — |
| 76 | LEGATO CAPITAL MANAGEMENT LLC | 26.2K +9.9K (+61.0%) | 4.96M +2.1M (+71.9%) | 0.14% +0.051 pp | 0.43% +0.113 pp | USD142.08 +33.1% | 9 qtrs — |
| 77 | GRANAHAN INVESTMENT MANAGEMENT, LLC | 26.1K +1.1K (+4.4%) | 4.93M +503.5K (+11.4%) | 0.13% +0.006 pp | 0.21% +0.030 pp | USD177.64 +6.4% | 2 qtrs — |
| 78 | CIBC WORLD MARKET INC. | 25.6K -33.5K (-56.7%) | 4.85M -5.6M (-53.7%) | 0.13% -0.173 pp | 0.01% -0.011 pp | USD108.18 +74.8% | 6 qtrs — |
| 79 | ISTHMUS PARTNERS, LLC | 24.7K -4.8K (-16.2%) | 4.67M -553.7K (-10.6%) | 0.13% -0.025 pp | 0.52% -0.640 pp | USD83.97 +125.2% | 43 qtrs — |
| 80 | ALLIANCEBERNSTEIN L.P. | 24.2K +1.9K (+8.6%) | 4.57M +628.1K (+15.9%) | 0.12% +0.010 pp | 0.00% +0.000 pp | USD103.22 +83.2% | 61 qtrs — |
| 81 | BESSEMER GROUP INC | 23.5K +22.8K (+3,051.5%) | 4.44M +4.3M (+3,266.7%) | 0.12% +0.118 pp | 0.01% +0.007 pp | USD188.51 +0.3% | 5 qtrs — |
| 82 | EDGESTREAM PARTNERS, L.P. | 22.9K +12.0K (+109.5%) | 4.33M +2.4M (+123.6%) | 0.12% +0.062 pp | 0.12% +0.065 pp | USD172.94 +9.3% | 3 qtrs — |
| 83 | EAM INVESTORS, LLC | 21.1K -9.1K (-30.1%) | 3.99M -1.3M (-24.2%) | 0.11% -0.047 pp | 0.44% -0.159 pp | USD177.14 +6.7% | 2 qtrs — |
| 84 | CALAMOS ADVISORS LLC | 21.0K +312.0 (+1.5%) | 3.98M +306.3K (+8.3%) | 0.11% +0.002 pp | 0.01% +0.001 pp | USD125.39 +50.8% | 13 qtrs — |
| 85 | UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 20.9K -934.0 (-4.3%) | 3.95M +83.9K (+2.2%) | 0.11% -0.005 pp | 0.01% +0.000 pp | USD105.79 +78.7% | 4 qtrs — |
| 86 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 20.0K +20.0K (+100.0%) | 3.79M +3.8M (+100.0%) | 0.10% +0.104 pp | 0.00% +0.002 pp | USD189.07 +0.0% | 1 qtrs NEW |
| 87 | WOODSTOCK CORP | 20.0K -20.0 (-0.1%) | 3.78M +235.1K (+6.6%) | 0.10% 0.000 pp | 0.32% +0.017 pp | USD68.54 +175.9% | 49 qtrs — |
| 88 | PRICE T ROWE ASSOCIATES INC /MD/ | 20.0K +1.1K (+5.7%) | 3.78M +428.0K (+12.8%) | 0.10% +0.006 pp | 0.00% +0.000 pp | USD108.55 +74.2% | 60 qtrs — |
| 89 | MOODY ALDRICH PARTNERS LLC | 19.6K -6.3K (-24.4%) | 3.70M -882.9K (-19.3%) | 0.10% -0.033 pp | 0.69% -0.179 pp | USD177.14 +6.7% | 2 qtrs — |
| 90 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 18.8K +486.0 (+2.7%) | 3.55M +310.3K (+9.6%) | 0.10% +0.003 pp | 0.00% +0.000 pp | USD72.25 +161.7% | 52 qtrs — |
| 91 | RAYMOND JAMES FINANCIAL INC | 18.8K -104.0 (-0.6%) | 3.55M +205.3K (+6.1%) | 0.10% -0.001 pp | 0.00% +0.000 pp | USD107.15 +76.5% | 5 qtrs — |
| 92 | STIFEL FINANCIAL CORP | 18.7K -1.8K (-8.7%) | 3.54M -93.7K (-2.6%) | 0.10% -0.009 pp | 0.00% 0.000 pp | USD96.01 +96.9% | 12 qtrs — |
| 93 | CITIGROUP INC | 18.3K -3.1K (-14.5%) | 3.46M -330.0K (-8.7%) | 0.09% -0.016 pp | 0.00% 0.000 pp | USD98.67 +91.6% | 54 qtrs — |
| 94 | GREAT WEST LIFE ASSURANCE CO /CAN/ | 16.8K -6.5K (-28.1%) | 3.16M -868.0K (-21.5%) | 0.09% -0.034 pp | 0.01% 0.000 pp | USD105.79 +78.7% | 49 qtrs — |
| 95 | LINDEN THOMAS ADVISORY SERVICES, LLC | 16.6K -231.0 (-1.4%) | 3.13M +156.8K (+5.3%) | 0.09% -0.001 pp | 0.32% +0.016 pp | USD72.43 +161.0% | 11 qtrs — |
| 96 | JANE STREET GROUP, LLC | 16.0K -35.9K (-69.2%) | 3.02M -6.2M (-67.1%) | 0.08% -0.185 pp | 0.00% -0.001 pp | USD168.46 +12.2% | 14 qtrs — |
| 97 | QUBE RESEARCH & TECHNOLOGIES LTD | 15.4K +11.8K (+323.8%) | 2.91M +2.3M (+352.4%) | 0.08% +0.061 pp | 0.00% +0.002 pp | USD170.72 +10.7% | 4 qtrs — |
| 98 | MARTINGALE ASSET MANAGEMENT L P | 15.3K -3.2K (-17.1%) | 2.90M -375.2K (-11.5%) | 0.08% -0.016 pp | 0.07% -0.009 pp | USD75.60 +150.1% | 12 qtrs — |
| 99 | CAPTRUST FINANCIAL ADVISORS | 14.6K -430.0 (-2.9%) | 2.76M +97.8K (+3.7%) | 0.08% -0.003 pp | 0.01% 0.000 pp | USD82.31 +129.7% | 10 qtrs — |
| 100 | CAXTON ASSOCIATES LLP | 14.5K +— (+0.0%) | 2.74M +173.1K (+6.7%) | 0.07% +0.000 pp | 0.05% -0.007 pp | USD177.14 +6.7% | 2 qtrs — |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.08
Bearish
Ratio by volume
0.48
Bearish
Buys
1
Sells
12
Shares acquired
5.0K
Shares disposed
10.5K
Cash buys
—
Cash sales
11.00
Net activity
-5,467
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-01 | Reardon Andrew | Officer | M-Exempt | A | Common Stock | 5,000 | 52.27 | 261.4K | 46,382 | D | ↗ |
| 2026-04-01 | Reardon Andrew | Officer | M-Exempt | A | Common Stock | 5,000 | 52.27 | 261.4K | 46,382 | D | ↗ |
| 2026-04-01 | KOZARICH JOHN W | Director | S-Sale | D | Common Stock | 43 | 202.91 | 8.7K | 42,412 | D | ↗ |
| 2026-03-23 | Sabba Stephen L | Director | S-Sale | D | Common Stock | 1,000 | 207.87 | 207.9K | 32,793 | D | ↗ |
| 2026-03-11 | Espinoza Octavio | Officer | M-Exempt | D | Employee Stock Option (right to buy) | 2,405 | 92.65 | 222.8K | 0 | D | ↗ |
| 2026-03-06 | LAMATTINA JOHN L | Director | M-Exempt | A | Common Stock | 2,161 | 114.15 | 246.7K | 32,885 | D | ↗ |
| 2026-03-04 | Reardon Andrew | Officer | S-Sale | D | Common Stock | 1,446 | 208.12 | 300.9K | 38,011 | D | ↗ |
| 2026-03-04 | Espinoza Octavio | Officer | M-Exempt | D | Employee Stock Option (right to buy) | 1,607 | 58.49 | 94.0K | 0 | D | ↗ |
| 2026-03-03 | Sabba Stephen L | Director | M-Exempt | D | Non- Qualified Stock Option (right to buy) | 2,034 | 69.51 | 141.4K | 0 | D | ↗ |
| 2026-03-02 | Reardon Andrew | Officer | A-Award | A | Common Stock | 4,513 | 0.00 | — | 41,382 | D | ↗ |
| 2026-03-02 | KOZARICH JOHN W | Director | S-Sale | D | Common Stock | 42 | 203.57 | 8.5K | 42,720 | D | ↗ |
| 2026-03-02 | Espinoza Octavio | Officer | A-Award | A | Employee Stock Option (right to buy) | 23,527 | 202.55 | 4.77M | 23,527 | D | ↗ |
| 2026-03-02 | Davis Todd C | Director / Officer | A-Award | A | Common Stock | 10,495 | 0.00 | — | 199,381 | D | ↗ |
| 2026-02-15 | Reardon Andrew | Officer | F-InKind | D | Common Stock | 992 | 183.83 | 182.4K | 36,869 | D | ↗ |
| 2026-02-15 | Espinoza Octavio | Officer | F-InKind | D | Common Stock | 1,270 | 183.83 | 233.5K | 33,012 | D | ↗ |
| 2026-02-15 | Davis Todd C | Director / Officer | F-InKind | D | Common Stock | 2,805 | 183.83 | 515.6K | 188,886 | D | ↗ |
| 2026-02-14 | Reardon Andrew | Officer | F-InKind | D | Common Stock | 3,211 | 183.83 | 590.3K | 34,528 | D | ↗ |
| 2026-02-14 | Espinoza Octavio | Officer | F-InKind | D | Common Stock | 3,761 | 183.83 | 691.4K | 32,204 | D | ↗ |
| 2026-02-14 | Davis Todd C | Director / Officer | A-Award | A | Common Stock | 39,644 | 0.00 | — | 213,585 | D | ↗ |
| 2026-02-02 | KOZARICH JOHN W | Director | S-Sale | D | Common Stock | 39 | 191.00 | 7.4K | 43,615 | D | ↗ |
| 2026-01-02 | KOZARICH JOHN W | Director | S-Sale | D | Common Stock | 102 | 188.96 | 19.3K | 43,907 | D | ↗ |
| 2025-12-31 | Espinoza Octavio | Officer | J-Other | A | Common Stock | 8 | 95.68 | 765.41 | 28,575 | D | ↗ |
| 2025-12-16 | Espinoza Octavio | Officer | M-Exempt | A | Common Stock | 1,194 | 52.84 | 63.1K | 27,380 | D | ↗ |
| 2025-12-12 | Espinoza Octavio | Officer | S-Sale | D | Common Stock | 1,804 | 188.31 | 339.7K | 26,186 | D | ↗ |
| 2025-12-08 | Aryeh Jason | Director | M-Exempt | A | Common Stock | 2,034 | 69.51 | 141.4K | 71,323 | D | ↗ |
| 2025-12-05 | Espinoza Octavio | Officer | F-InKind | D | Common Stock | 1,862 | 184.87 | 344.2K | 27,990 | D | ↗ |
| 2025-12-04 | Davis Todd C | Director / Officer | G-Gift | D | Common Stock | 130 | 0.00 | — | 161,337 | D | ↗ |
| 2025-12-01 | KOZARICH JOHN W | Director | S-Sale | D | Common Stock | 30 | 200.02 | 6.0K | 44,121 | D | ↗ |
| 2025-11-07 | LAMATTINA JOHN L | Director | M-Exempt | D | Non-Qualified Stock Option (right to buy) | 2,145 | 66.13 | 141.8K | 0 | D | ↗ |
| 2025-11-07 | Gray Nancy Ryan | Director | M-Exempt | A | Common Stock | 3,556 | 66.19 | 235.4K | 11,650 | D | ↗ |
| 2025-11-03 | KOZARICH JOHN W | Director | S-Sale | D | Common Stock | 84 | 189.00 | 15.9K | 44,971 | D | ↗ |
| 2025-10-01 | KOZARICH JOHN W | Director | S-Sale | D | Common Stock | 24 | 177.60 | 4.3K | 45,498 | D | ↗ |
| 2025-09-23 | Aryeh Jason | Director | S-Sale | D | Common Stock | 4,628 | 170.96 | 791.2K | 70,243 | D | ↗ |
| 2025-09-22 | Zimmermann Martine | Director | F-InKind | D | Common Stock | 115 | 170.77 | 19.6K | 4,443 | D | ↗ |
| 2025-09-02 | KOZARICH JOHN W | Director | S-Sale | D | Common Stock | 267 | 161.51 | 43.1K | 45,722 | D | ↗ |
| 2025-08-10 | Reardon Andrew | Officer | F-InKind | D | Common Stock | 1,325 | 150.06 | 198.8K | 30,811 | D | ↗ |
| 2025-08-01 | KOZARICH JOHN W | Director | S-Sale | D | Common Stock | 467 | 131.88 | 61.6K | 45,989 | D | ↗ |
| 2025-07-10 | KOZARICH JOHN W | Director | S-Sale | D | Common Stock | 934 | 125.00 | 116.8K | 46,456 | D | ↗ |
| 2025-06-30 | Reardon Andrew | Officer | J-Other | A | Common Stock | 233 | 91.08 | 21.2K | 32,136 | D | ↗ |
| 2025-06-30 | Espinoza Octavio | Officer | J-Other | A | Common Stock | 224 | 91.08 | 20.4K | 29,852 | D | ↗ |
| 2025-06-30 | Davis Todd C | Director / Officer | J-Other | A | Common Stock | 233 | 91.08 | 21.2K | 161,467 | D | ↗ |
| 2025-06-23 | Reardon Andrew | Officer | S-Sale | D | Common Stock | 500 | 114.08 | 57.0K | 31,903 | D | ↗ |
| 2025-06-10 | Reardon Andrew | Officer | S-Sale | D | Common Stock | 500 | 114.54 | 57.3K | 32,403 | D | ↗ |
| 2025-06-06 | Zimmermann Martine | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 5,783 | 105.99 | 612.9K | 5,783 | D | ↗ |
| 2025-06-06 | Sabba Stephen L | Director | A-Award | A | Common Stock | 1,209 | 0.00 | — | 33,793 | D | ↗ |
| 2025-06-06 | LAMATTINA JOHN L | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 5,783 | 105.99 | 612.9K | 5,783 | D | ↗ |
| 2025-06-06 | KOZARICH JOHN W | Director | A-Award | A | Common Stock | 1,209 | 0.00 | — | 47,390 | D | ↗ |
| 2025-06-06 | Haas Jason | Director | A-Award | A | Common Stock | 1,209 | 0.00 | — | 6,606 | D | ↗ |
| 2025-06-06 | Gray Nancy Ryan | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 5,783 | 105.99 | 612.9K | 5,783 | D | ↗ |
| 2025-06-06 | Aryeh Jason | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 5,783 | 105.99 | 612.9K | 5,783 | D | ↗ |
| 2025-05-15 | Reardon Andrew | Officer | S-Sale | D | Common Stock | 1,000 | 104.00 | 104.0K | 32,903 | D | ↗ |
| 2025-05-09 | Espinoza Octavio | Officer | P-Purchase | A | Common Stock | 1,000 | 103.89 | 103.9K | 27,432 | D | ↗ |
| 2025-05-09 | Davis Todd C | Director / Officer | P-Purchase | A | Common Stock | 5,523 | 105.67 | 583.6K | 161,234 | D | ↗ |
| 2025-04-01 | Sabba Stephen L | Director | M-Exempt | A | Common Stock | 2,406 | 52.30 | 125.8K | 32,584 | D | ↗ |
| 2025-03-04 | Reardon Andrew | Officer | A-Award | A | Common Stock | 6,415 | 0.00 | — | 34,783 | D | ↗ |
| 2025-03-04 | Espinoza Octavio | Officer | A-Award | A | Employee Stock Option (right to buy) | 32,717 | 115.26 | 3.77M | 32,717 | D | ↗ |
| 2025-03-04 | Davis Todd C | Director / Officer | A-Award | A | Common Stock | 21,382 | 0.00 | — | 151,724 | D | ↗ |
| 2025-02-15 | Reardon Andrew | Officer | F-InKind | D | Common Stock | 876 | 120.00 | 105.1K | 28,368 | D | ↗ |
| 2025-02-15 | Espinoza Octavio | Officer | F-InKind | D | Common Stock | 1,024 | 120.00 | 122.9K | 25,882 | D | ↗ |
| 2025-02-15 | Davis Todd C | Director / Officer | F-InKind | D | Common Stock | 2,231 | 120.00 | 267.7K | 134,597 | D | ↗ |
| 2025-02-14 | Reardon Andrew | Officer | F-InKind | D | Common Stock | 2,775 | 120.00 | 333.0K | 26,687 | D | ↗ |
| 2025-02-14 | Espinoza Octavio | Officer | F-InKind | D | Common Stock | 2,757 | 120.00 | 330.8K | 23,319 | D | ↗ |
| 2025-02-14 | Davis Todd C | Director / Officer | F-InKind | D | Common Stock | 6,966 | 120.00 | 835.9K | 136,828 | D | ↗ |
| 2025-01-17 | KOZARICH JOHN W | Director | M-Exempt | A | Common Stock | 2,406 | 52.30 | 125.8K | 46,181 | D | ↗ |
| 2024-12-23 | Espinoza Octavio | Officer | S-Sale | D | Common Stock | 2,104 | 116.37 | 244.9K | 20,647 | D | ↗ |
| 2024-12-05 | Espinoza Octavio | Officer | F-InKind | D | Common Stock | 1,859 | 123.51 | 229.6K | 22,751 | D | ↗ |
| 2024-11-27 | LAMATTINA JOHN L | Director | M-Exempt | A | Common Stock | 2,406 | 52.30 | 125.8K | 31,921 | D | ↗ |
| 2024-09-23 | Reardon Andrew | Officer | S-Sale | D | Common Stock | 2,000 | 99.60 | 199.2K | 22,534 | D | ↗ |
| 2024-09-23 | Korenberg Matthew E | Officer | M-Exempt | D | Employee Stock Option (right to buy) | 395 | 49.99 | 19.7K | 0 | D | ↗ |
| 2024-09-20 | Korenberg Matthew E | Officer | M-Exempt | A | Common Stock | 4,982 | 49.99 | 249.1K | 57,052 | D | ↗ |
| 2024-09-20 | Espinoza Octavio | Officer | S-Sale | D | Common Stock | 275 | 103.86 | 28.6K | 25,410 | D | ↗ |
| 2024-09-17 | Espinoza Octavio | Officer | M-Exempt | A | Common Stock | 69 | 57.22 | 3.9K | 25,885 | — | ↗ |
| 2024-09-16 | Korenberg Matthew E | Officer | M-Exempt | A | Common Stock | 3,340 | 60.94 | 203.5K | 54,008 | — | ↗ |
| 2024-08-28 | Reardon Andrew | Officer | M-Exempt | A | Common Stock | 1,500 | 52.27 | 78.4K | 24,034 | — | ↗ |
| 2024-08-28 | Espinoza Octavio | Officer | M-Exempt | D | Incentive Stock Option (right to buy) | 546 | 70.04 | 38.2K | 0 | — | ↗ |
| 2024-08-26 | Korenberg Matthew E | Officer | S-Sale | D | Common Stock | 6,177 | 105.02 | 648.7K | 54,722 | — | ↗ |
| 2024-08-23 | Korenberg Matthew E | Officer | S-Sale | D | Common Stock | 2,037 | 104.09 | 212.0K | 65,174 | — | ↗ |
| 2024-08-22 | Korenberg Matthew E | Officer | S-Sale | D | Common Stock | 1,157 | 105.54 | 122.1K | 67,211 | — | ↗ |
| 2024-08-10 | Reardon Andrew | Officer | F-InKind | D | Common Stock | 897 | 100.16 | 89.8K | 21,637 | D | ↗ |
| 2024-08-09 | Korenberg Matthew E | Officer | S-Sale | D | Common Stock | 18,245 | 98.50 | 1.80M | 68,368 | — | ↗ |
| 2024-08-08 | Davis Todd C | Director / Officer | P-Purchase | A | Common Stock | 2,500 | 97.39 | 243.5K | 123,010 | — | ↗ |
| 2024-06-28 | Reardon Andrew | Officer | J-Other | A | Common Stock | 329 | 60.71 | 20.0K | 22,534 | — | ↗ |
| 2024-06-28 | Korenberg Matthew E | Officer | J-Other | A | Common Stock | 350 | 60.71 | 21.2K | 86,613 | — | ↗ |
| 2024-06-28 | Espinoza Octavio | Officer | J-Other | A | Common Stock | 267 | 60.71 | 16.2K | 23,646 | — | ↗ |
| 2024-06-28 | Davis Todd C | Director / Officer | J-Other | A | Common Stock | 350 | 60.71 | 21.2K | 120,510 | — | ↗ |
| 2024-06-14 | Zimmermann Martine | Director | A-Award | A | Common Stock | 1,252 | 0.00 | — | 3,537 | — | ↗ |
| 2024-06-14 | Sabba Stephen L | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 5,444 | 80.06 | 435.8K | 5,444 | — | ↗ |
| 2024-06-14 | LAMATTINA JOHN L | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 5,444 | 80.06 | 435.8K | 5,444 | — | ↗ |
| 2024-06-14 | KOZARICH JOHN W | Director | A-Award | A | Common Stock | 1,252 | 0.00 | — | 43,775 | — | ↗ |
| 2024-06-14 | Haas Jason | Director | A-Award | A | Common Stock | 1,252 | 0.00 | — | 5,397 | — | ↗ |
| 2024-06-14 | Gray Nancy Ryan | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 5,444 | 80.06 | 435.8K | 5,444 | — | ↗ |
| 2024-06-14 | Aryeh Jason | Director | A-Award | A | Common Stock | 1,252 | 0.00 | — | 78,080 | — | ↗ |
| 2024-05-17 | Espinoza Octavio | Officer | M-Exempt | D | Employee Stock Option (right to buy) | 1,544 | 63.62 | 98.2K | 18,456 | — | ↗ |
| 2024-05-16 | Espinoza Octavio | Officer | S-Sale | D | Common Stock | 2,264 | 86.00 | 194.7K | 21,618 | — | ↗ |
| 2024-05-15 | Espinoza Octavio | Officer | S-Sale | D | Common Stock | 5,873 | 86.01 | 505.1K | 23,882 | — | ↗ |
| 2024-05-14 | Korenberg Matthew E | Officer | S-Sale | D | Common Stock | 13,638 | 85.08 | 1.16M | 86,783 | — | ↗ |
| 2024-05-13 | Korenberg Matthew E | Officer | S-Sale | D | Common Stock | 3,440 | 84.54 | 290.8K | 100,421 | — | ↗ |
| 2024-05-09 | Reardon Andrew | Officer | M-Exempt | A | Common Stock | 10,000 | 52.27 | 522.7K | 32,205 | — | ↗ |
| 2024-05-09 | Gray Nancy Ryan | Director | S-Sale | D | Common Stock | 934 | 83.20 | 77.7K | 5,633 | — | ↗ |
| 2024-04-30 | Aryeh Jason | Director | M-Exempt | A | Common Stock | 2,406 | 52.30 | 125.8K | 76,828 | — | ↗ |
| 2024-04-24 | KOZARICH JOHN W | Director | M-Exempt | A | Common Stock | 2,893 | 39.35 | 113.8K | 42,523 | — | ↗ |
| 2024-03-25 | Davis Todd C | Director / Officer | M-Exempt | D | Non-Qualified Stock Option (right to buy) | 7,448 | 46.20 | 344.1K | 0 | — | ↗ |
| 2024-03-05 | Sabba Stephen L | Director | S-Sale | D | Common Stock | 1,893 | 74.30 | 140.6K | 28,926 | — | ↗ |
| 2024-03-05 | Aryeh Jason | Director | M-Exempt | D | Non-Qualified Stock Option (right to buy) | 2,893 | 39.35 | 113.8K | 0 | — | ↗ |
| 2024-02-28 | Espinoza Octavio | Officer | M-Exempt | A | Common Stock | 799 | 55.75 | 44.5K | 29,430 | — | ↗ |
| 2024-02-27 | Reardon Andrew | Officer | A-Award | A | Common Stock | 7,208 | 0.00 | — | 22,205 | — | ↗ |
| 2024-02-27 | Korenberg Matthew E | Officer | A-Award | A | Common Stock | 14,416 | 0.00 | — | 103,861 | — | ↗ |
| 2024-02-27 | Espinoza Octavio | Officer | A-Award | A | Common Stock | 7,208 | 0.00 | — | 28,631 | — | ↗ |
| 2024-02-27 | Davis Todd C | Director / Officer | A-Award | A | Common Stock | 32,436 | 0.00 | — | 104,145 | — | ↗ |
| 2024-02-15 | Reardon Andrew | Officer | F-InKind | D | Common Stock | 593 | 74.65 | 44.3K | 14,997 | — | ↗ |
| 2024-02-15 | Korenberg Matthew E | Officer | F-InKind | D | Common Stock | 4,778 | 74.65 | 356.7K | 89,445 | — | ↗ |
| 2024-02-15 | Espinoza Octavio | Officer | F-InKind | D | Common Stock | 1,479 | 74.65 | 110.4K | 21,423 | — | ↗ |
| 2024-02-15 | Davis Todd C | Director / Officer | F-InKind | D | Common Stock | 1,381 | 74.65 | 103.1K | 71,709 | — | ↗ |
| 2024-01-02 | Korenberg Matthew E | Officer | F-InKind | D | Common Stock | 2,917 | 72.31 | 210.9K | 94,223 | — | ↗ |
| 2023-12-29 | Reardon Andrew | Officer | J-Other | A | Common Stock | 179 | 60.71 | 10.9K | 15,590 | — | ↗ |
| 2023-12-05 | Korenberg Matthew E | Officer | F-InKind | D | Common Stock | 1,984 | 59.61 | 118.3K | 97,140 | — | ↗ |
| 2023-12-05 | Espinoza Octavio | Officer | F-InKind | D | Common Stock | 1,269 | 59.61 | 75.6K | 22,902 | — | ↗ |
| 2023-10-01 | Espinoza Octavio | Officer | F-InKind | D | Common Stock | 346 | 59.92 | 20.7K | 24,171 | — | ↗ |
| 2023-09-22 | Zimmermann Martine | Director | A-Award | A | Employee Stock Option (right to buy) | 11,345 | 59.08 | 670.3K | 11,345 | — | ↗ |
| 2023-09-22 | Davis Todd C | Director / Officer | P-Purchase | A | Common Stock | 4,000 | 59.38 | 237.5K | 73,090 | — | ↗ |
| 2023-08-10 | Reardon Andrew | Officer | F-InKind | D | Common Stock | 897 | 68.73 | 61.7K | 15,411 | — | ↗ |
| 2023-06-30 | Korenberg Matthew E | Officer | J-Other | A | Common Stock | 376 | 56.78 | 21.3K | 99,124 | — | ↗ |
| 2023-06-30 | Espinoza Octavio | Officer | J-Other | A | Common Stock | 375 | 56.78 | 21.3K | 24,517 | — | ↗ |
| 2023-06-09 | Sabba Stephen L | Director | A-Award | D | Non-Qualified Stock Option (right to buy) | 5,461 | 73.76 | 402.8K | 5,461 | — | ↗ |
| 2023-06-09 | LAMATTINA JOHN L | Director | A-Award | A | Common Stock | 1,142 | 0.00 | — | 28,263 | — | ↗ |
| 2023-06-09 | KOZARICH JOHN W | Director | A-Award | A | Common Stock | 1,142 | 0.00 | — | 39,630 | — | ↗ |
| 2023-06-09 | Haas Jason | Director | A-Award | A | Common Stock | 1,142 | 0.00 | — | 4,145 | — | ↗ |
| 2023-06-09 | Gray Nancy Ryan | Director | A-Award | A | Common Stock | 1,142 | 0.00 | — | 6,567 | — | ↗ |
| 2023-06-09 | Davis Todd C | Director / Officer | F-InKind | D | Common Stock | 420 | 73.76 | 31.0K | 69,090 | — | ↗ |
| 2023-06-09 | Aryeh Jason | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 5,461 | 73.76 | 402.8K | 5,461 | — | ↗ |
| 2023-05-16 | KOZARICH JOHN W | Director | S-Sale | D | Common Stock | 4,444 | 77.20 | 343.1K | 38,488 | — | ↗ |
| 2023-05-11 | GOLDMAN SACHS GROUP INC | 10% Owner | — | I | Convertible Bonds | 173,246 | 248.48 | 43.05M | 0 | — | ↗ |
| 2023-05-10 | Sabba Stephen L | Director | M-Exempt | D | Non-Qualified Stock Option (right to buy) | 6,408 | 18.82 | 120.6K | 927 | — | ↗ |
| 2023-05-08 | KOZARICH JOHN W | Director | S-Sale | D | Common Stock | 589 | 77.10 | 45.4K | 42,213 | — | ↗ |
| 2023-03-24 | Reardon Andrew | Officer | S-Sale | D | Common Stock | 300 | 69.92 | 21.0K | 16,308 | — | ↗ |
| 2023-02-23 | Reardon Andrew | Officer | A-Award | A | Employee Stock Option (right to buy) | 15,393 | 75.09 | 1.16M | 15,393 | — | ↗ |
| 2023-02-23 | Korenberg Matthew E | Officer | A-Award | A | Employee Stock Option (right to buy) | 24,628 | 75.09 | 1.85M | 24,628 | — | ↗ |
| 2023-02-23 | Espinoza Octavio | Officer | A-Award | A | Employee Stock Option (right to buy) | 16,419 | 75.09 | 1.23M | 16,419 | — | ↗ |
| 2023-02-23 | Davis Todd C | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 46,178 | 75.09 | 3.47M | 46,178 | — | ↗ |
| 2023-02-15 | Korenberg Matthew E | Officer | F-InKind | D | Common Stock | 2,890 | 72.98 | 210.9K | 89,679 | — | ↗ |
| 2023-02-15 | Espinoza Octavio | Officer | F-InKind | D | Common Stock | 849 | 72.98 | 62.0K | 18,096 | — | ↗ |
| 2022-12-30 | Espinoza Octavio | Officer | J-Other | A | Common Stock | 275 | 56.78 | 15.6K | 18,945 | — | ↗ |
| 2022-12-28 | Korenberg Matthew E | Officer | F-InKind | D | Common Stock | 3,859 | 66.29 | 255.8K | 92,569 | — | ↗ |
| 2022-12-28 | HIGGINS JOHN L | Director | F-InKind | D | Common Stock | 5,289 | 66.29 | 350.6K | 417,695 | — | ↗ |
| 2022-12-22 | Sabba Stephen L | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 6,623 | 67.03 | 443.9K | 6,623 | — | ↗ |
| 2022-12-22 | LAMATTINA JOHN L | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 4,484 | 67.03 | 300.6K | 4,484 | — | ↗ |
| 2022-12-22 | Korenberg Matthew E | Officer | A-Award | A | Employee Stock Option (right to buy) | 25,967 | 0.00 | — | 25,967 | — | ↗ |
| 2022-12-22 | KOZARICH JOHN W | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 6,623 | 67.03 | 443.9K | 6,623 | — | ↗ |
| 2022-12-22 | HIGGINS JOHN L | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 92,932 | 67.03 | 6.23M | 92,932 | — | ↗ |
| 2022-12-22 | Gray Nancy Ryan | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 3,050 | 67.03 | 204.4K | 3,050 | — | ↗ |
| 2022-12-22 | Espinoza Octavio | Officer | A-Award | A | Employee Stock Option (right to buy) | 6,620 | 67.03 | 443.7K | 6,620 | — | ↗ |
| 2022-12-22 | Davis Todd C | Officer | A-Award | A | Employee Stock Option (right to buy) | 2,081 | 0.00 | — | 2,081 | — | ↗ |
| 2022-12-22 | Aryeh Jason | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 4,484 | 0.00 | — | 4,484 | — | ↗ |
| 2022-12-16 | HIGGINS JOHN L | Director | S-Sale | D | Common Stock | 10,000 | 61.87 | 618.7K | 422,984 | — | ↗ |
| 2022-12-13 | Korenberg Matthew E | Officer | A-Award | A | Common Stock | 14,000 | 0.00 | — | 96,428 | — | ↗ |
| 2022-12-13 | Espinoza Octavio | Officer | A-Award | A | Employee Stock Option (right to buy) | 20,000 | 0.00 | — | 20,000 | — | ↗ |
| 2022-12-12 | HIGGINS JOHN L | Director | D-Return | D | Common Stock | 3,944 | 64.80 | 255.6K | 432,984 | — | ↗ |
| 2022-12-05 | Davis Todd C | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 132,000 | 69.70 | 9.20M | 132,000 | — | ↗ |
| 2022-11-30 | Reardon Andrew | Officer | F-InKind | D | Common Stock | 1,073 | 72.90 | 78.2K | 10,940 | — | ↗ |
| 2022-11-30 | Korenberg Matthew E | Officer | F-InKind | D | Common Stock | 3,593 | 72.90 | 261.9K | 82,428 | — | ↗ |
| 2022-11-30 | HIGGINS JOHN L | Officer | F-InKind | D | Common Stock | 9,803 | 72.90 | 714.6K | 416,928 | — | ↗ |
| 2022-11-30 | Espinoza Octavio | Officer | F-InKind | D | Common Stock | 1,187 | 72.90 | 86.5K | 7,670 | — | ↗ |
| 2022-11-18 | HIGGINS JOHN L | Director / Officer | M-Exempt | D | Non-Qualified Stock Option (right to buy) | 10,000 | 12.78 | 127.8K | 40,335 | — | ↗ |
| 2022-11-17 | HIGGINS JOHN L | Officer | S-Sale | D | Common Stock | 10,000 | 78.32 | 783.2K | 416,731 | — | ↗ |
| 2022-11-09 | Espinoza Octavio | Officer | S-Sale | D | Common Stock | 1,696 | 75.64 | 128.3K | 8,857 | — | ↗ |
| 2022-11-01 | Reardon Andrew | Officer | — | D | Employee Stock Option (right to buy) | 72,944 | 52.27 | 3.81M | — | — | ↗ |
| 2022-11-01 | Patel Sunil | Director | D-Return | D | Common Stock | 1,004 | 0.00 | — | 28,820 | — | ↗ |
| 2022-11-01 | Korenberg Matthew E | Officer | A-Award | A | Common Stock | 27,714 | 0.00 | — | 86,021 | — | ↗ |
| 2022-11-01 | HIGGINS JOHN L | Officer | A-Award | A | Common Stock | 45,922 | 0.00 | — | 424,731 | — | ↗ |
| 2022-11-01 | FOEHR MATTHEW W | Director | D-Return | D | Common Stock | 20,304 | 0.00 | — | 162,187 | — | ↗ |
| 2022-11-01 | Espinoza Octavio | Officer | — | — | Common Stock | 0 | 0.00 | — | 1,696 | D | ↗ |
| 2022-11-01 | Cochran Jennifer R. | Director | D-Return | D | Employee Stock Option (right to buy) | 4,340 | 0.00 | — | 0 | — | ↗ |
| 2022-11-01 | Boyce Sarah | Director | D-Return | D | Common Stock | 1,004 | 0.00 | — | 2,892 | — | ↗ |
| 2022-11-01 | Berkman Charles S | Director | D-Return | D | Common Stock | 11,944 | 0.00 | — | 23,825 | — | ↗ |
| 2022-09-16 | HIGGINS JOHN L | Director / Officer | S-Sale | D | Common Stock | 1,000 | 88.06 | 88.1K | 366,180 | — | ↗ |
| 2022-09-15 | HIGGINS JOHN L | Director / Officer | S-Sale | D | Common Stock | 2,000 | 90.00 | 180.0K | 367,180 | — | ↗ |
| 2022-06-30 | Korenberg Matthew E | Officer | J-Other | A | Common Stock | 164 | 75.84 | 12.4K | 52,532 | — | ↗ |
| 2022-06-30 | HIGGINS JOHN L | Officer | J-Other | A | Common Stock | 164 | 75.84 | 12.4K | 369,180 | — | ↗ |
| 2022-06-29 | Haas Jason | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 5,907 | 0.00 | — | 5,907 | — | ↗ |
| 2022-06-10 | Sabba Stephen L | Director | A-Award | D | Non-Qualified Stock Option (right to buy) | 4,340 | 79.29 | 344.1K | 4,340 | — | ↗ |
| 2022-06-10 | Patel Sunil | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 4,340 | 79.29 | 344.1K | 4,340 | — | ↗ |
| 2022-06-10 | LAMATTINA JOHN L | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 4,340 | 79.29 | 344.1K | 4,340 | — | ↗ |
| 2022-06-10 | Korenberg Matthew E | Officer | A-Award | A | Common Stock | 8,062 | 0.00 | — | 52,368 | — | ↗ |
| 2022-06-10 | KOZARICH JOHN W | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 4,340 | 79.29 | 344.1K | 4,340 | — | ↗ |
| 2022-06-10 | HIGGINS JOHN L | Officer | A-Award | A | Common Stock | 20,423 | 0.00 | — | 369,016 | — | ↗ |
| 2022-06-10 | Gray Nancy Ryan | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 4,340 | 79.29 | 344.1K | 4,340 | — | ↗ |
| 2022-06-10 | FOEHR MATTHEW W | Officer | A-Award | A | Common Stock | 9,137 | 0.00 | — | 182,491 | — | ↗ |
| 2022-06-10 | Davis Todd C | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 4,340 | 79.29 | 344.1K | 4,340 | — | ↗ |
| 2022-06-10 | Cochran Jennifer R. | Director | A-Award | A | Common Stock | 1,004 | 0.00 | — | 2,165 | — | ↗ |
| 2022-06-10 | Boyce Sarah | Director | A-Award | A | Common Stock | 1,004 | 0.00 | — | 3,896 | — | ↗ |
| 2022-06-10 | Berkman Charles S | Officer | A-Award | A | Common Stock | 5,375 | 0.00 | — | 35,769 | — | ↗ |
| 2022-06-10 | Aryeh Jason | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 4,340 | 79.29 | 344.1K | 4,340 | — | ↗ |
| 2022-05-13 | FOEHR MATTHEW W | Officer | P-Purchase | A | Common Stock | 2,500 | 82.76 | 206.9K | 173,354 | — | ↗ |
| 2022-05-10 | HIGGINS JOHN L | Director / Officer | S-Sale | D | 0.75% Convertible Senior Notes due 2023 | 0 | 248.48 | — | 0 | — | ↗ |
| 2022-05-09 | HIGGINS JOHN L | Officer | M-Exempt | D | Non-Qualified Stock Option (right to buy) | 8,000 | 0.00 | — | 57,616 | — | ↗ |
| 2022-05-05 | Korenberg Matthew E | Officer | A-Award | A | Employee Stock Option (right to buy) | 30,189 | 0.00 | — | 30,189 | — | ↗ |
| 2022-05-05 | HIGGINS JOHN L | Officer | A-Award | A | Employee Stock Option (right to buy) | 76,478 | 0.00 | — | 76,478 | — | ↗ |
| 2022-05-05 | FOEHR MATTHEW W | Officer | A-Award | A | Employee Stock Option (right to buy) | 34,214 | 90.68 | 3.10M | 34,214 | — | ↗ |
| 2022-05-05 | Berkman Charles S | Officer | A-Award | A | Employee Stock Option (right to buy) | 20,126 | 0.00 | — | 20,126 | — | ↗ |
| 2022-02-28 | KOZARICH JOHN W | Director | M-Exempt | A | Common Stock | 7,335 | 12.53 | 91.9K | 42,117 | — | ↗ |
Executive team
Top executives
EBIT / Employee
2.34M
Shares Outstanding
20.04M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Matthew Korenberg Former President and Chief Operating Officer | 385.5K | — | 6.72M | 5.80M | 142.8K | 118.3K | 13.17M | 95.09% | ↗ |
| 2 | 2024 | Tavo Espinoza Chief Financial Officer | 469.6K | — | 1.43M | 1.14M | 250.0K | 7.4K | 3.30M | 77.96% | ↗ |
| 3 | 2024 | Andrew Reardon Chief Legal Officer and Secretary | 452.0K | — | 1.43M | 1.14M | 240.0K | 7.4K | 3.27M | 78.62% | ↗ |
| 4 | 2023 | Todd C. Davis Chief Executive Officer | 650.0K | — | 3.38M | 1.79M | 390.0K | 10.0K | 6.22M | 83.11% | ↗ |
| 5 | 2023 | Matthew Korenberg President and Chief Operating Officer | 549.9K | — | 1.80M | 953.6K | 275.0K | 6.9K | 3.59M | 76.81% | ↗ |
| 6 | 2023 | Matthew Korenberg Former President and Chief Operating Officer | 549.9K | — | 1.80M | 953.6K | 275.0K | 6.9K | 3.59M | 76.81% | ↗ |
| 7 | 2023 | Tavo Espinoza Chief Financial Officer | 433.0K | — | 1.20M | 635.8K | 173.2K | 7.4K | 2.45M | 74.96% | ↗ |
| 8 | 2023 | Andrew Reardon Chief Legal Officer and Secretary | 434.3K | — | 1.13M | 596.0K | 173.7K | 6.9K | 2.34M | 73.69% | ↗ |
| 9 | 2022 | John L. Higgins Former Chief Executive Officer | 675.3K | — | 4.56M | 5.18M | — | 6.35M | 16.76M | 58.11% | ↗ |
| 10 | 2022 | Matthew Korenberg Former President and Chief Operating Officer | 519.9K | — | 2.69M | 3.09M | 234.2K | 6.9K | 6.54M | 88.37% | ↗ |
| 11 | 2022 | Matthew Korenberg President and Chief Operating Officer | 519.9K | — | 2.69M | 3.09M | 234.2K | 6.9K | 6.54M | 88.37% | ↗ |
| 12 | 2022 | Todd C. Davis Chief Executive Officer | 49.2K | — | 79.6K | 5.00M | — | 65.0K | 5.20M | 97.80% | ↗ |
| 13 | 2022 | Matthew W. Foehr Former President and Chief Operating Officer | 451.1K | — | 2.04M | 1.40M | — | 115.4K | 4.01M | 85.87% | ↗ |
| 14 | 2022 | Tavo Espinoza Chief Financial Officer | 330.1K | — | 1.39M | 1.43M | 119.7K | 7.4K | 3.27M | 86.03% | ↗ |
| 15 | 2022 | Andrew Reardon Chief Legal Officer and Secretary | 172.9K | — | 1.02M | 1.75M | 62.3K | 2.9K | 3.01M | 92.08% | ↗ |
| 16 | 2022 | Charles S. Berkman Former Senior Vice President, General Counsel and Secretary | 396.9K | — | 1.20M | 823.6K | — | 12.2K | 2.43M | 83.19% | ↗ |
| 17 | 2021 | John L. Higgins Former Chief Executive Officer | 696.6K | — | 6.02M | 2.34M | 522.4K | 7.4K | 9.59M | 87.21% | ↗ |
| 18 | 2021 | John L. Higgins Chief Executive Officer | 696.6K | — | 6.02M | 2.34M | 522.4K | 7.4K | 9.59M | 87.21% | ↗ |
| 19 | 2021 | Matthew Korenberg Executive Vice President, Finance and Chief Financial Officer | 497.3K | — | 4.89M | 1.08M | 248.6K | 7.3K | 6.73M | 88.80% | ↗ |
| 20 | 2021 | Matthew Korenberg President and Chief Operating Officer | 497.3K | — | 4.89M | 1.08M | 248.6K | 7.3K | 6.73M | 88.80% | ↗ |
| 21 | 2021 | Matthew W. Foehr President and Chief Operating Officer | 518.9K | — | 3.15M | 1.23M | 259.5K | 130.6K | 5.28M | 82.79% | ↗ |
| 22 | 2021 | Matthew W. Foehr Former President and Chief Operating Officer | 518.9K | — | 3.15M | 1.23M | 259.5K | 130.6K | 5.28M | 82.79% | ↗ |
| 23 | 2021 | Charles S. Berkman Former Senior Vice President, General Counsel and Secretary | 451.7K | — | 1.67M | 649.3K | 203.3K | 10.9K | 2.98M | 77.66% | ↗ |
| 24 | 2021 | Charles S. Berkman Senior Vice President and General Counsel | 451.7K | — | 1.67M | 649.3K | 203.3K | 10.9K | 2.98M | 77.66% | ↗ |
| 25 | 2020 | John L. Higgins Former Chief Executive Officer | 668.3K | — | 2.28M | 2.39M | 501.3K | 6.2K | 5.84M | 79.88% | ↗ |
| 26 | 2020 | John L. Higgins Chief Executive Officer | 668.3K | — | 2.28M | 2.39M | 501.3K | 6.2K | 5.84M | 79.88% | ↗ |
| 27 | 2020 | Matthew W. Foehr Former President and Chief Operating Officer | 503.8K | — | 1.24M | 1.30M | 277.1K | 158.0K | 3.48M | 73.06% | ↗ |
| 28 | 2020 | Matthew W. Foehr President and Chief Operating Officer | 503.8K | — | 1.24M | 1.30M | 277.1K | 158.0K | 3.48M | 73.06% | ↗ |
| 29 | 2020 | Matthew Korenberg Executive Vice President, Finance and Chief Financial Officer | 482.8K | — | 1.15M | 1.21M | 265.6K | 5.7K | 3.11M | 75.76% | ↗ |
| 30 | 2020 | Matthew Korenberg President and Chief Operating Officer | 482.8K | — | 1.15M | 1.21M | 265.6K | 5.7K | 3.11M | 75.76% | ↗ |
| 31 | 2020 | Charles S. Berkman Former Senior Vice President, General Counsel and Secretary | 441.9K | — | 644.2K | 675.8K | 176.8K | 6.2K | 1.94M | 67.87% | ↗ |
| 32 | 2020 | Charles S. Berkman Senior Vice President and General Counsel | 441.9K | — | 644.2K | 675.8K | 176.8K | 6.2K | 1.94M | 67.87% | ↗ |
| 33 | 2019 | John L. Higgins Chief Executive Officer | 648.2K | — | 2.93M | 2.89M | 291.7K | 6.0K | 6.77M | 86.03% | ↗ |
| 34 | 2019 | John L. Higgins, Chief Executive Officer | 648.2K | — | 2.93M | 2.89M | 291.7K | 6.0K | 6.77M | 86.03% | ↗ |
| 35 | 2019 | Matthew W. Foehr President and Chief Operating Officer | 487.5K | — | 1.71M | 1.69M | 195.0K | 164.8K | 4.24M | 80.04% | ↗ |
| 36 | 2019 | Matthew W. Foehr, President and Chief Operating Officer | 487.5K | — | 1.71M | 1.69M | 195.0K | 164.8K | 4.24M | 80.04% | ↗ |
| 37 | 2019 | Matthew Korenberg Executive Vice President, Finance and Chief Financial Officer | 466.7K | — | 1.47M | 1.45M | 186.7K | 5.7K | 3.57M | 81.54% | ↗ |
| 38 | 2019 | Matthew Korenberg, Executive Vice President, Finance and Chief Financial Officer | 466.7K | — | 1.47M | 1.45M | 186.7K | 5.7K | 3.57M | 81.54% | ↗ |
| 39 | 2019 | Charles S. Berkman Senior Vice President and General Counsel | 427.6K | — | 733.3K | 722.8K | 136.9K | 6.5K | 2.03M | 71.83% | ↗ |
| 40 | 2019 | Charles S. Berkman, Senior Vice President and General Counsel | 427.6K | — | 733.3K | 722.8K | 136.9K | 6.5K | 2.03M | 71.83% | ↗ |
| 41 | 2018 | John L. Higgins Chief Executive Officer | 627.4K | — | 2.78M | 2.38M | 517.6K | 6.0K | 6.31M | 81.75% | ↗ |
| 42 | 2018 | John L. Higgins, Chief Executive Officer | 627.4K | — | 2.78M | 2.38M | 517.6K | 6.0K | 6.31M | 81.75% | ↗ |
| 43 | 2018 | Matthew W. Foehr, President and Chief Operating Officer | 458.9K | — | 1.36M | 1.16M | 252.4K | 87.5K | 3.32M | 75.97% | ↗ |
| 44 | 2018 | Matthew W. Foehr President and Chief Operating Officer | 458.9K | — | 1.36M | 1.16M | 252.4K | 87.5K | 3.32M | 75.97% | ↗ |
| 45 | 2018 | Matthew Korenberg Executive Vice President, Finance and Chief Financial Officer | 428.4K | — | 1.08M | 921.6K | 235.6K | 5.4K | 2.67M | 74.91% | ↗ |
| 46 | 2018 | Matthew Korenberg, Executive Vice President, Finance and Chief Financial Officer | 428.4K | — | 1.08M | 921.6K | 235.6K | 5.4K | 2.67M | 74.91% | ↗ |
| 47 | 2018 | Charles S. Berkman, Senior Vice President and General Counsel | 402.5K | — | 624.0K | 533.5K | 177.1K | 6.5K | 1.74M | 66.39% | ↗ |
| 48 | 2018 | Charles S. Berkman Senior Vice President and General Counsel | 402.5K | — | 624.0K | 533.5K | 177.1K | 6.5K | 1.74M | 66.39% | ↗ |
| 49 | 2017 | John L. Higgins, Chief Executive Officer | 611.7K | 30.0K | 2.11M | 2.20M | 550.5K | 7.5K | 5.51M | 78.24% | ↗ |
| 50 | 2017 | Matthew W. Foehr, President and Chief Operating Officer | 442.1K | 30.0K | 1.39M | 1.28M | 265.3K | 52.7K | 3.46M | 77.16% | ↗ |
| 51 | 2017 | Matthew Korenberg, Executive Vice President, Finance and Chief Financial Officer | 403.4K | 30.0K | 736.6K | 768.3K | 242.1K | 5.4K | 2.19M | 68.85% | ↗ |
| 52 | 2017 | Charles S. Berkman, Senior Vice President and General Counsel | 362.8K | — | 466.5K | 486.6K | 174.2K | 8.8K | 1.50M | 63.59% | ↗ |
| 53 | 2016 | John L. Higgins, Chief Executive Officer | 574.0K | — | 1.99M | 2.39M | 387.4K | 6.0K | 5.35M | 81.93% | ↗ |
| 54 | 2016 | Matthew W. Foehr, President and Chief Operating Officer | 429.3K | — | 973.9K | 1.17M | 193.2K | 75.0K | 2.84M | 75.45% | ↗ |
| 55 | 2016 | Matthew Korenberg, Executive Vice President, Finance and Chief Financial Officer | 378.8K | — | 664.0K | 797.7K | 118.5K | 7.9K | 1.97M | 74.32% | ↗ |
| 56 | 2016 | Matthew Korenberg, Vice President, Finance and Chief Financial Officer | 378.8K | — | 664.0K | 797.7K | 118.5K | 7.9K | 1.97M | 74.32% | ↗ |
| 57 | 2016 | Charles S. Berkman, Senior Vice President and General Counsel | 329.2K | — | 376.3K | 452.0K | 136.4K | 6.3K | 1.30M | 63.71% | ↗ |
| 58 | 2016 | Charles S. Berkman, Vice President and General Counsel | 329.2K | — | 376.3K | 452.0K | 136.4K | 6.3K | 1.30M | 63.71% | ↗ |
| 59 | 2015 | John L. Higgins, President and Chief Executive Officer | 547.3K | — | 1.79M | 1.81M | 392.0K | 6.4K | 4.55M | 79.22% | ↗ |
| 60 | 2015 | John L. Higgins, Chief Executive Officer | 547.3K | — | 1.79M | 1.81M | 392.0K | 6.4K | 4.55M | 79.22% | ↗ |
| 61 | 2015 | Matthew W. Foehr, President and Chief Operating Officer | 410.5K | — | 1.25M | 1.36M | 196.0K | 143.5K | 3.36M | 77.66% | ↗ |
| 62 | 2015 | Matthew W. Foehr, Executive VP and Chief Operating Officer | 410.5K | — | 1.25M | 1.36M | 196.0K | 143.5K | 3.36M | 77.66% | ↗ |
| 63 | 2015 | Matthew Korenberg, Executive Vice President, Finance and Chief Financial Officer | 140.7K | — | 1.26M | 1.34M | 56.3K | 5.5K | 2.80M | 92.77% | ↗ |
| 64 | 2015 | Matthew Korenberg, Vice President, Finance and Chief Financial Officer | 140.7K | — | 1.26M | 1.34M | 56.3K | 5.5K | 2.80M | 92.77% | ↗ |
| 65 | 2015 | Nishan de Silva, Former VP, Finance and Strategy and Chief Financial Officer | 137.9K | — | 666.5K | 672.6K | — | 5.1K | 1.48M | 90.35% | ↗ |
| 66 | 2015 | Charles S. Berkman, Senior Vice President and General Counsel | 308.6K | — | 512.6K | 517.4K | 117.9K | 5.9K | 1.46M | 70.43% | ↗ |
| 67 | 2015 | Charles S. Berkman, Vice President and General Counsel | 308.6K | — | 512.6K | 517.4K | 117.9K | 5.9K | 1.46M | 70.43% | ↗ |
| 68 | 2015 | Melanie J. Herman, Chief Accounting Officer and former Interim Chief Financial Officer | 191.0K | — | 67.5K | 290.0K | 38.2K | 45.9K | 632.6K | 56.51% | ↗ |
| 69 | 2014 | John L. Higgins, Chief Executive Officer | 510.2K | — | 595.4K | 4.55M | 383.1K | 5.7K | 6.05M | 85.13% | ↗ |
| 70 | 2014 | John L. Higgins, President and Chief Executive Officer | 510.2K | — | 595.4K | 4.55M | 383.1K | 5.7K | 6.05M | 85.13% | ↗ |
| 71 | 2014 | Matthew W. Foehr, President and Chief Operating Officer | 375.4K | — | 372.1K | 3.12M | 187.9K | 5.4K | 4.06M | 85.98% | ↗ |
| 72 | 2014 | Matthew W. Foehr, Executive VP and Chief Operating Officer | 375.4K | — | 372.1K | 3.12M | 187.9K | 5.4K | 4.06M | 85.98% | ↗ |
| 73 | 2014 | Nishan de Silva, Former VP, Finance and Strategy and Chief Financial Officer | 300.5K | — | 223.3K | 2.16M | 120.4K | 5.7K | 2.81M | 84.80% | ↗ |
| 74 | 2014 | Charles S. Berkman, Vice President and General Counsel | 288.9K | — | 186.1K | 958.5K | 115.7K | 5.7K | 1.55M | 73.61% | ↗ |
| 75 | 2013 | John L. Higgins, President and Chief Executive Officer | 500.3K | — | 559.4K | 1.57M | 375.2K | 2.8K | 3.00M | 70.77% | ↗ |
| 76 | 2013 | John L. Higgins, President and Chief Executive Officer | 500.3K | — | 559.4K | 1.57M | 375.2K | 2.8K | 3.00M | 70.77% | ↗ |
| 77 | 2013 | Matthew W. Foehr, Executive VP and Chief Operating Officer | 368.1K | — | 398.2K | 1.01M | 184.1K | 2.8K | 1.97M | 71.77% | ↗ |
| 78 | 2013 | Matthew W. Foehr, Executive VP and Chief Operating Officer | 368.1K | — | 398.2K | 1.01M | 184.1K | 2.8K | 1.97M | 71.77% | ↗ |
| 79 | 2013 | Nishan de Silva, Former VP, Finance and Strategy and Chief Financial Officer | 294.6K | — | 109.6K | 624.1K | 94.3K | 2.6K | 1.13M | 65.21% | ↗ |
| 80 | 2013 | Nishan de Silva, M.D., M.B.A., VP, Finance and Strategy and Chief Financial Officer | 294.6K | — | 109.6K | 624.1K | 94.3K | 2.6K | 1.13M | 65.21% | ↗ |
| 81 | 2013 | John P. Sharp, Former VP, Finance and Chief Financial Officer | 301.2K | — | 54.8K | 277.4K | 96.4K | 2.9K | 732.7K | 45.33% | ↗ |
| 82 | 2013 | Charles S. Berkman, Vice President and General Counsel | 283.4K | — | 54.8K | 277.4K | 113.3K | 2.9K | 731.8K | 45.39% | ↗ |
| 83 | 2013 | Charles S. Berkman, Vice President and General Counsel | 283.4K | — | 54.8K | 277.4K | 113.3K | 2.9K | 731.8K | 45.39% | ↗ |
| 84 | 2012 | John L. Higgins, President and Chief Executive Officer | 484.5K | — | 86.8K | 1.43M | 363.4K | 2.7K | 2.37M | 64.13% | ↗ |
| 85 | 2012 | Nishan de Silva, M.D., M.B.A., VP, Finance and Strategy and Chief Financial Officer | 246.3K | — | 144.7K | 803.2K | 98.5K | 39.1K | 1.33M | 71.18% | ↗ |
| 86 | 2012 | Matthew W. Foehr, Executive Vice President and Chief Operating Officer | 359.6K | — | 144.7K | 535.5K | 179.8K | 2.5K | 1.22M | 55.65% | ↗ |
| 87 | 2012 | Matthew W. Foehr, Executive VP and Chief Operating Officer | 359.6K | — | 144.7K | 535.5K | 179.8K | 2.5K | 1.22M | 55.65% | ↗ |
| 88 | 2012 | John P. Sharp, Former VP, Finance and Chief Financial Officer | 292.5K | — | 72.4K | 312.4K | 102.4K | 3.0K | 782.6K | 49.16% | ↗ |
| 89 | 2012 | John P. Sharp, Vice President, Finance and Chief Financial Officer | 292.5K | — | 72.4K | 312.4K | 102.4K | 3.0K | 782.6K | 49.16% | ↗ |
| 90 | 2012 | Charles S. Berkman, Vice President and General Counsel | 275.2K | — | 72.4K | 223.1K | 110.1K | 4.5K | 685.2K | 43.12% | ↗ |
| 91 | 2011 | John L. Higgins, President and Chief Executive Officer | 423.9K | — | 150.8K | — | 317.9K | 2.5K | 1.63M | 9.23% | ↗ |
| 92 | 2011 | Matthew W. Foehr, Executive Vice President and Chief Operating Officer | 248.0K | — | 249.3K | 869.8K | 124.0K | 2.6K | 1.49M | 74.92% | ↗ |
| 93 | 2011 | Matthew W. Foehr, Executive VP and Chief Operating Officer | 248.0K | — | 166.2K | — | 124.0K | 2.6K | 1.41M | 11.78% | ↗ |
| 94 | 2011 | John P. Sharp, Vice President, Finance and Chief Financial Officer | 265.0K | — | 30.2K | 192.6K | 106.0K | 3.3K | 597.0K | 37.30% | ↗ |
| 95 | 2011 | John P. Sharp, Former VP, Finance and Chief Financial Officer | 265.0K | — | 30.2K | — | 106.0K | 3.3K | 597.0K | 5.05% | ↗ |
| 96 | 2011 | Charles S. Berkman, Vice President and General Counsel | 249.7K | — | 30.2K | — | 99.9K | 2.8K | 478.9K | 6.30% | ↗ |
| 97 | 2011 | Nishan de Silva, M.D., M.B.A., VP, Finance and Strategy and Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
| 98 | 2010 | John L. Higgins, President and Chief Executive Officer | 420.0K | — | 124.5K | — | 223.7K | 2.5K | 1.20M | 10.40% | ↗ |
| 99 | 2010 | John P. Sharp, Vice President, Finance and Chief Financial Officer | 262.6K | — | 29.9K | — | 74.6K | 2.8K | 479.2K | 6.24% | ↗ |
| 100 | 2010 | Charles S. Berkman, Vice President and General Counsel | 247.5K | — | 29.9K | — | 70.3K | 2.5K | 459.5K | 6.50% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Todd C. Davis | Chief Executive Officer & Director | 2M | male |
| Octavio Espinoza | Chief Financial Officer | 895.5K | male |
| Andrew T. Reardon | Chief Legal Officer & Secretary | 758.8K | male |
| Melanie J. Herman | Executive Director of Investor Relations and Financial Planning & Analysis | 275.1K | female |
| Patrick Lucy | Senior Vice President & CBO Protein Expression Business | — | male |
| Paul J. Hadden | Senior Vice President of Investments & Business Development | — | male |
| Richard Baxter | Senior VP of Investment Operations | — | male |
| Scott Plesha | Chief Executive Officer of Pelthos Therapeutics | — | male |
| Vincent D. Antle | Senior Vice President of Technical Operations & QA - Capitsol | — | — |
| Karen R. Reeves | Senior Vice President of Investments & Head of Clinical Strategy | — | — |
| Keith Marschke | Senior Vice President of Biology & Scientific Affairs | — | — |
| Lauren Hay | Vice President of Strategic Planning & Investment Analytics | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Political Trading Activity (25M)
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2026-01-15 | 2026-02-13 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2026-01-05 | 2026-02-13 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2020-10-22 | 2020-12-03 | Katherine M. Clark | MA05 | Self | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2020-04-03 | 2020-05-29 | Katherine M. Clark | MA05 | Self | Purchase | $1,001 - $15,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for LGND
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
